Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.2 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.2 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.2 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |